Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Investors Count

1

Trianta Immunotherapies Funding, Trianta Immunotherapies Valuation & Trianta Immunotherapies Revenue

1 Fundings

Trianta Immunotherapies's latest funding round was a Acquired for on January 27, 2014.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/27/2014

Acquired

1

Date

1/27/2014

Round

Acquired

Amount

Investors

Valuation

Revenue

Sources

1

Trianta Immunotherapies Investors

1 Investors

Trianta Immunotherapies has 1 investors. MediGene invested in Trianta Immunotherapies's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/27/2014

1/27/2014

1
Acquired

Corporation

Germany

First funding

1/27/2014

Last Funding

1/27/2014

Investor

Rounds

1
Acquired

Board Seats

Type

Corporation

Location

Germany

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.